Robert W. Baird initiated coverage on shares of Sharps Compliance (NASDAQ:SMED) in a research report report published on Wednesday, July 24th, Stock Target Advisor reports. The firm issued a buy rating and a $4.50 target price on the industrial products company’s stock.
A number of other research analysts also recently weighed in on the stock. Zacks Investment Research downgraded shares of Sharps Compliance from a hold rating to a strong sell rating in a research report on Saturday, May 25th. Barrington Research restated a buy rating and set a $4.50 price objective on shares of Sharps Compliance in a research report on Tuesday, May 21st. Finally, Roth Capital initiated coverage on shares of Sharps Compliance in a research report on Wednesday, July 24th. They set a buy rating and a $4.50 price objective on the stock.
Shares of NASDAQ SMED opened at $3.62 on Wednesday. The business has a 50 day moving average price of $3.61. The company has a market capitalization of $58.44 million, a P/E ratio of -90.50, a PEG ratio of 1.62 and a beta of 0.24. Sharps Compliance has a 52-week low of $2.97 and a 52-week high of $4.22. The company has a current ratio of 2.49, a quick ratio of 1.95 and a debt-to-equity ratio of 0.04.In other Sharps Compliance news, Director Parris H. Holmes, Jr. bought 40,000 shares of Sharps Compliance stock in a transaction on Thursday, June 13th. The stock was acquired at an average cost of $3.31 per share, with a total value of $132,400.00. Following the completion of the acquisition, the director now owns 942,027 shares in the company, valued at $3,118,109.37. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last ninety days, insiders have acquired 46,250 shares of company stock valued at $153,075. 20.70% of the stock is owned by corporate insiders.
Hedge funds have recently made changes to their positions in the business. Lapides Asset Management LLC increased its stake in shares of Sharps Compliance by 13.3% in the second quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock worth $586,000 after purchasing an additional 19,300 shares in the last quarter. Wells Fargo & Company MN grew its stake in Sharps Compliance by 8.3% during the second quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock valued at $1,512,000 after acquiring an additional 32,600 shares in the last quarter. Finally, Quantum Capital Management grew its stake in Sharps Compliance by 0.6% during the first quarter. Quantum Capital Management now owns 522,569 shares of the industrial products company’s stock valued at $1,913,000 after acquiring an additional 3,223 shares in the last quarter. 19.81% of the stock is owned by institutional investors and hedge funds.
About Sharps Compliance
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Recommended Story: What does a bar chart mean for investors?
Receive News & Ratings for Sharps Compliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sharps Compliance and related companies with MarketBeat.com’s FREE daily email newsletter.